| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.03 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |